Epigenomics AG

  • WKN: A11QW5
  • ISIN: DE000A11QW50
  • Land: Deutschland

Nachricht vom 29.10.2019 | 10:28

DGAP-DD: Epigenomics AG english


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

29.10.2019 / 10:27
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Dr.
First name: Helge
Last name(s): Lubenow

2. Reason for the notification

a) Position / status
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Epigenomics AG

b) LEI
549300X1C4U862NDLN97 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Financial instrument linked to a share or a debt instrument
Description: Subscription right, ISIN DE000A255FM4

b) Nature of the transaction
Granting of 4,050 subscription rights as part of a capital increase with subscription rights

c) Price(s) and volume(s)
Price(s) Volume(s)
not numberable not numberable

d) Aggregated information
Price Aggregated volume
not numberable not numberable

e) Date of the transaction
2019-10-24; UTC+1

f) Place of the transaction
Outside a trading venue



29.10.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Media and Games Invest wächst dynamisch und profitabel

Innerhalb des Konzerns Media and Games Invest sind der wachstumsstarke Game-Publisher gamigo AG sowie Unternehmen aus dem dynamischen Bereich „Digital Media“ gebündelt. Der Wachstumskurs der Gesellschaft soll sowohl auf Basis eines anhaltenden anorganischen Wachstums sowie durch den Ausbau des bestehenden Geschäftes fortgesetzt werden. Im Rahmen unserer Initial-Coverage-Studie haben wir ein Kursziel von 1,90 € je Aktie ermittelt und vergeben das Rating KAUFEN..

Aktueller Webcast

SeaChange Corporation

Third Quarter Fiscal Year 2020 Results

04. Dezember 2019

Aktuelle Research-Studie

Aves One AG

Original-Research: Aves One AG (von GBC AG): BUY

06. Dezember 2019